Uterine thermal balloon therapy under local anaesthesia for the treatment of menorrhagia: a pilot study

Human Reproduction
Hervé FernandezF Audibert

Abstract

This study evaluates the use of local anaesthesia in a subset of patients undergoing uterine thermal balloon endometrial ablation for the treatment of menorrhagia. Out of 51 patients with dysfunctional uterine bleeding, 18 were included for uterine balloon therapy under local anaesthesia. Inclusion criteria were dysfunctional bleeding with absence of organic lesions in the uterine cavity, adequate relaxation and pain control during physical examination and diagnostic hysteroscopy, and patient desire to avoid a general anaesthetic. Paracervical block was performed with 20 ml of dilute 1% lignocaine HCl with epinephrine 1:200,000. Success of the procedure was defined as amenorrhoea, hypomenorrhoea, or eumenorrhoea. The median follow-up period was 13.9 +/- 5 months and 11 patients (61%) had follow-up of >1 year. Treatment led to a significant decrease in menstrual flow, duration, and pad count in all patients (P < 0.0001). No intra-operative complications occurred. A pain scale (level 1-10) was used to evaluate the patients' tolerance of the procedure (mean 3.8 +/- 1.3). In light of these successful and well tolerated procedures, thermal balloon endometrial ablation, utilizing local anaesthesia, appears practical as an office-base...Continue Reading

Citations

Sep 7, 2007·Archives of Gynecology and Obstetrics·C IavazzoA Liapis
May 10, 2003·Fertility and Sterility·Pui Ling LeungPong Mo Yuen
Sep 13, 2003·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Ingrid A A van Zon-RabelinkRuurd de Graaf
Oct 25, 2000·The Journal of the American Association of Gynecologic Laparoscopists·S L CorsonT G Vancaillie
Sep 5, 2001·Acta Obstetricia Et Gynecologica Scandinavica·F WieserF Nagele
Aug 19, 2000·Clinical Obstetrics and Gynecology·A P Korn
Jan 19, 1999·Obstetrical & Gynecological Survey·S A StabinskyJ L Breen
Feb 24, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·C Kremer, S Duffy
Feb 2, 2011·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·R K Kalkat, R S V Cartmill
Jan 1, 2007·Medical Journal, Armed Forces India·K KapurM Biswas
Jul 4, 2009·Journal of Minimally Invasive Gynecology·Mark H Glasser
Jun 5, 2007·Best Practice & Research. Clinical Obstetrics & Gynaecology·George A Vilos, Fawaz Edris
Jul 2, 2009·The Journal of Obstetrics and Gynaecology Research·David KuzelOndrej Viklicky
Nov 10, 2004·Fertility and Sterility·Thomas Justin Clark, Janesh Kumar Gupta
Apr 22, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Ingrid A A Van Zon-RabelinkRuurd De Graaf
Aug 23, 2005·Best Practice & Research. Clinical Obstetrics & Gynaecology·Lawahd Hassan, Michael J Gannon
Jul 31, 2012·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Mohamad Sayed Abdellah, Ali Mahmoud Mohamad Mostafa Elsaman
Dec 21, 2002·Best Practice & Research. Clinical Anaesthesiology·Mary C Mushambi, Karin Williamson
Dec 25, 2016·BJOG : an International Journal of Obstetrics and Gynaecology·Ima ReindersM Y Bongers
Jun 8, 1999·Human Reproduction·F TresserraR Labastida
Oct 19, 2002·The Journal of the American Association of Gynecologic Laparoscopists·Ingrid Hung LokPong Mo Yuen
May 5, 1999·The Journal of the American Association of Gynecologic Laparoscopists·A LissakH Abramovici
Nov 2, 2005·The Journal of Family Planning and Reproductive Health Care·K F McAllister, A Bigrigg
Oct 3, 2013·The Cochrane Database of Systematic Reviews·Thumwadee TangsiriwatthanaMalinee Laopaiboon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.